| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Disparate outcomes in Hispanic patients with metabolic dysfunction-associated steatotic liver disease/steatohepatitis and type 2 diabetes: Large cohort study
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Joseph Matthew Gosnell, George Golovko, Esteban Arroyave, Akshata Moghe, Michael L Kueht, Omar Abdul Saldarriaga, Kevin H McKinney, Heather L Stevenson and Monique R Ferguson |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Institute for Translational Sciences at the University of Texas Medical Branch, supported in part by a Clinical and Translational Science Award from the National Center for Advancing Translational Sciences at the National Institutes of Health |
UL1TR001439 |
| Moody Endowment Grant |
2014-07 |
|
| Corresponding Author |
Joseph Matthew Gosnell, MD, MS, Doctor, Doctor, Department of Pathology, University of Texas Medical Branch, 301 University Blvd, Galveston, TX 77555, United States. jogosnel@utmb.edu |
| Key Words |
Metabolic dysfunction-associated steatotic liver disease; Metabolic dysfunction-associated steatohepatitis; Hispanic; Diabetes mellitus; TriNetX; Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis; Outcomes |
| Core Tip |
We reviewed the outcome data between Hispanic and non-Hispanic patients diagnosed with metabolic dysfunction-associated steatotic liver disease/metabolic dysfunction-associated steatohepatitis in both University of Texas Medical Branch (UTMB) and separately in a United States national cohort to determine if disparities in outcome were confined to a geographically-defined region, i.e., Southeast Texas, or observed nationally. Outcomes studied included rates of all-cause mortality, hepatocellular carcinoma, type 2 diabetes mellitus, and liver fibrosis/cirrhosis between the Hispanic and non-Hispanic. Outcome disparities between Hispanic and non-Hispanic groups were observed in the UTMB and United States cohorts at similar rates in all outcomes with the exception of all-cause mortality in the UTMB cohort. |
| Publish Date |
2024-05-10 11:51 |
| Citation |
Gosnell JM, Golovko G, Arroyave E, Moghe A, Kueht ML, Saldarriaga OA, McKinney KH, Stevenson HL, Ferguson MR. Disparate outcomes in Hispanic patients with metabolic dysfunction-associated steatotic liver disease/steatohepatitis and type 2 diabetes: Large cohort study. World J Diabetes 2024; 15(5): 886-897 |
| URL |
https://www.wjgnet.com/1948-9358/full/v15/i5/886.htm |
| DOI |
10.4239/wjd.v15.i5.886 |
